Pharma News - Chemdiv

Clinical Research Forum Names Top 10 Research Efforts of 2021

The Clinical Research Forum, a nonprofit organization based in Washington, D.C., has unveiled its picks to receive its annual Top 10 Clinical Research Achievement Award, a recognition it gives to r...

FDA Approves Bayer’s Kerendia for Chronic Kidney Disease Associated With Type 2 Diabetes

Bayer’s Kerendia (finerenone) has secured FDA approval for treatment of patients with chronic kidney disease (CKD) associated with type 2 diabetes.

Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation

Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain stimulator.

GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal

GlaxoSmithKline has slammed the brakes on its pivotal maternal respiratory syncytial virus (RSV) vaccine program after a safety assessment, potentially handing an advantage to Pfizer in a close rac...

FDA Grants Immune-Onc’s IO-202 Fast-Track Status for Treating AML

The FDA has granted Fast-Track designation to Immune-Onc Therapeutics’ IO-202, an experimental myeloid checkpoint inhibitor developed for treating patients with relapsed or refractory acute myelo...

Sackler family owners of Purdue Pharma propose up to $6 billion opioid settlement

The Sackler family owners of Purdue Pharma have proposed a new and larger settlement worth up to $6 billion to resolve allegations that the OxyContin maker and its owners contributed to the deadly ...

BioMarin says gene therapy hold will endure as FDA questions cancer risk

BioMarin Pharmaceutical will need to run additional preclinical studies to assess the "theoretical" cancer risk of a rare disease gene therapy it's developing, information the Food and Drug Adminis...

Merck and Ridgeback Statement on Clinical Trial of Hetero’s Generic Molnupiravir

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today issued the following statement regarding the clinical trial of Hetero’s generic molnupiravir. ...

How an OTC cough med could serve as a steppingstone for creating heart rhythm drugs

The cough medicine dextromethorphan has been shown to treat inherited heart arrhythmia disorders in mouse models and human cells.

FDA approves treatment for anemia in adults with rare inherited disorderves treatment for anemia in adults with rare inherited disorder

FDA has approved Pyrukynd (mitapivat) tablets to treat hemolytic anemia (a disorder in which red blood cells are destroyed faster than they can be made) in adults with pyruvate kinase (PK) d...

ChemDiv’s Triazoles Library contains 4000 compounds

The triazole moiety is present in a large number of FDA-approved drugs, drug candidates, and lead compounds. This heterocycle, for example, is considered as a privileged structure of antifungal com...

A global view on fatty liver and diabetes helps to fight other non-communicable diseases and COVID-19

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes. ...